BDBM350670 1-(4-bromophenyl)-3-[4- (hydroxymethyl)-2,5-dioxo-4- (propan-2-yl)imidazolidin-1- yl]urea::US10208071, Compound 132::US10434112, Compound 132::US10799518, Compound 132

SMILES CC(C)C1(CO)NC(=O)N(NC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=CEZPOASFNJODLF-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350670   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350670(1-(4-bromophenyl)-3-[4- (hydroxymethyl)-2,5-dioxo-...)
Affinity DataEC50:  16.2nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350670(1-(4-bromophenyl)-3-[4- (hydroxymethyl)-2,5-dioxo-...)
Affinity DataEC50:  16.2nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350670(1-(4-bromophenyl)-3-[4- (hydroxymethyl)-2,5-dioxo-...)
Affinity DataEC50:  1.62E+4nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent